CN Stock MarketDetailed Quotes

000627 Hubei Biocause Pharmaceutical

Watchlist
  • 5.13
  • +0.47+10.09%
Market Closed Dec 12 15:00 CST
25.35BMarket Cap-32.88P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Biocause Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
4.54B
--
-41.49%
EPS
--
<0.01
--
--
Analyst Rating
No Data

Hubei Biocause Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

No Data

Hubei Biocause Pharmaceutical Earnings Reports

  • Tianmao Group: Report for the third quarter of 2024

    Oct 30 12:00 ET

  • Tianmao Group: Tianmao Group\'s performance forecast for the first three quarters of 2024

    Oct 14 12:00 ET

  • Tianmao Group: Guohua Life 2024 Semi-Annual Report

    Aug 30 12:00 ET

  • Tianmao Group: 2024 Semi-Annual Report

    Aug 30 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Sprint Precision Technologies
    688605
    71.56 +533.84%
    Jiangsu Jingxue Insulation Technology
    301010
    18.10 +20.03%
    Global Infotech
    300465
    18.82 +20.03%
    Hydsoft Technology
    301316
    25.98 +20.00%
    SGSG Science&Technology
    300561
    64.68 +20.00%

    See the daily top gainer.

    Investment Theme Insurance Concept
    Insurance Concept
    Intraday+1.84%
    MSCI concept
    MSCI concept
    Intraday+1.06%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday+1.01%